Quality Control (QC) in Clinical Research

Detail-oriented QC that delivers well-formatted, accurate, and consistent regulatory documents every time.

Thank you for the excellent QC, which gives us great comfort in the quality of the final document.
Medical Writing Director
Midsize Pharma Sponsor

QC services at MMS come complete with innovative, streamlined processes to ensure the creation of high-quality documents, delivered on-time with fewer drafts. This eases document development for Sponsor study teams and keeps their programs running at full-strength.

With fast and adaptive QC timelines, a global presence in multiple time zones, and a commitment to quality, you can expect the highest level of satisfaction for every project.

Accurate & Consistent QC Reviews

MMS provides QC as a service (QCAS) on documents we author, or as a stand-alone service. We employ a robust QC process that operates effectively or can be adapted to meet Sponsor-specific requirements. This design ensures the accuracy and consistency of data within any clinical or scientific document.

Additionally, we check documents against templates and style guides for proper formatting and style points. Using our proven method, we can QC any clinical, non-clinical, or scientific document quickly and efficiently. Our deep expertise in QCing medical writing deliverables expands across nearly all therapeutic areas.

The MMS QC Group has expertise in a broad range of regulatory documents, including:

  • Core documents, such as clinical study protocols, informed consent forms (ICF), clinical study reports (CSR), aggregate reports and common technical document (CTD) modules
  • Less common documents, such as briefing packages and responses to global health authority questions
  • Unique documents provided by Sponsors that need bespoke QC review
24-Hour Global QC Coverage

MMS is flexible across numerous times zones. With team members across India, South Africa, and the US, we can accommodate tight timelines and short notice. Our team meets daily to properly resource the best fit team member for each document type or therapeutic area.

We have the ability to train and grow new team members quickly to accommodate a growing number of requests.

MMS Standalone QC Request Portal

To further improve your experience with MMS’ QC service, we have developed a QC web portal to allow you to book your standalone QCs using unique login credentials issued to you by MMS IT. Requesting your standalone QCs through the portal is fast and simple, gives you complete visibility of your current and past requests, ability to check on the status of ongoing QCs or edit your requests in any way, upload new sources and documents for QC, and download your completed QC files from the portal.

The portal sends you notification email at s at each step of the process to keep you actively appraised of the QC’s progress, including one when the QC is complete which contains a download link so that you don’t need to visit the portal to collect your QCd document, should you choose.

The portal is secure so that only you can see your QCs, and anyone at your institution with portal credentials can view all of your institution’s requests.

If you are an MMS client and are interested in our standalone QC service and would like a demonstration of the portal, please speak with your MMS project manager, who will be happy to arrange that for you.

Suggested For You

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development

perspectives

October 15th, 2024

Putting the Action in Diversity Action Plans and the Real-Time Data Visualization Technology Needed to Ensure It Happens

news

October 15th, 2024

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry